INY-03-041 trihydrochloride, a potent and highly selective PROTAC-based pan-AKT degrader, comprises Ipatasertib, an ATP-competitive AKT inhibitor, conjugated to Lenalidomide. It effectively inhibits AKT1, AKT2, and AKT3 with IC50 values of 2.0, 6.8, and
Molecular Weight:
907.8
Formula:
C44H59Cl4N7O5
* VAT and and shipping costs not included. Errors and price changes excepted
